Mark De Rosch is Chief Operating Officer of Aura Biosciences, Inc.. Currently has a direct ownership of 58,635 shares of AURA, which is worth approximately $642,639. The most recent transaction as insider was on Jan 19, 2023, when has been sold 42,250 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 58.6K
0% 3M change
0% 12M change
Total Value Held $642,639

Mark De Rosch Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 19 2023
BUY
Grant, award, or other acquisition
-
42,250 Added 41.88%
58,635 Common Stock
Oct 31 2022
SELL
Open market or private sale
$13,892 $12.46 p/Share
1,115 Reduced 6.37%
16,385 Common Stock
Oct 28 2021
BUY
Grant, award, or other acquisition
-
17,500 Added 50.0%
17,500 Common Stock
MDR

Mark De Rosch

Chief Operating Officer
Cambridge, MA

Track Institutional and Insider Activities on AURA

Follow Aura Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AURA shares.

Notify only if

Insider Trading

Get notified when an Aura Biosciences, Inc. insider buys or sells AURA shares.

Notify only if

News

Receive news related to Aura Biosciences, Inc.

Track Activities on AURA